1. Home
  2. BCYC vs PLAY Comparison

BCYC vs PLAY Comparison

Compare BCYC & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • PLAY
  • Stock Information
  • Founded
  • BCYC 2009
  • PLAY 1982
  • Country
  • BCYC United Kingdom
  • PLAY United States
  • Employees
  • BCYC N/A
  • PLAY N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • PLAY Restaurants
  • Sector
  • BCYC Health Care
  • PLAY Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • PLAY Nasdaq
  • Market Cap
  • BCYC 566.5M
  • PLAY 678.9M
  • IPO Year
  • BCYC 2019
  • PLAY 1995
  • Fundamental
  • Price
  • BCYC $8.22
  • PLAY $21.96
  • Analyst Decision
  • BCYC Buy
  • PLAY Buy
  • Analyst Count
  • BCYC 10
  • PLAY 6
  • Target Price
  • BCYC $25.00
  • PLAY $27.00
  • AVG Volume (30 Days)
  • BCYC 333.0K
  • PLAY 878.3K
  • Earning Date
  • BCYC 05-01-2025
  • PLAY 06-10-2025
  • Dividend Yield
  • BCYC N/A
  • PLAY N/A
  • EPS Growth
  • BCYC N/A
  • PLAY N/A
  • EPS
  • BCYC N/A
  • PLAY 1.46
  • Revenue
  • BCYC $25,722,000.00
  • PLAY $2,132,700,000.00
  • Revenue This Year
  • BCYC N/A
  • PLAY $3.48
  • Revenue Next Year
  • BCYC $1.83
  • PLAY $5.75
  • P/E Ratio
  • BCYC N/A
  • PLAY $15.04
  • Revenue Growth
  • BCYC N/A
  • PLAY N/A
  • 52 Week Low
  • BCYC $6.10
  • PLAY $15.08
  • 52 Week High
  • BCYC $28.67
  • PLAY $52.73
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.16
  • PLAY 56.28
  • Support Level
  • BCYC $8.00
  • PLAY $19.89
  • Resistance Level
  • BCYC $8.73
  • PLAY $22.99
  • Average True Range (ATR)
  • BCYC 0.48
  • PLAY 1.08
  • MACD
  • BCYC 0.02
  • PLAY 0.04
  • Stochastic Oscillator
  • BCYC 33.33
  • PLAY 66.77

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.

Share on Social Networks: